Post Tagged with: "ASCO14"

Thoughts on combination therapies

0 / May 31, 2014 9:27 am

orning it’s Day 1 of ASCO 2014 and it’s already a mad house. The combo Phase 1 study of ipilimumab, dabrafenib (BRAF inhib) and trametinib (MEK inhib) has been presented. Interestingly, the doublet combination (Ipi plus Dab) did not […]

Shopping Cart (0 Items)
Your cart is empty!


Subtotal: $0.00
Total: $0.00